A detailed history of Employees Retirement System Of Texas transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Employees Retirement System Of Texas holds 44,679 shares of RXRX stock, worth $323,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,679
Previous 50,351 11.26%
Holding current value
$323,475
Previous $378,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.92 - $8.6 $33,578 - $48,779
-5,672 Reduced 11.26%
44,679 $294,000
Q2 2024

Aug 14, 2024

BUY
$7.35 - $10.05 $43,754 - $59,827
5,953 Added 13.41%
50,351 $378,000
Q1 2024

May 14, 2024

BUY
$9.13 - $15.52 $200,860 - $341,440
22,000 Added 98.22%
44,398 $443,000
Q4 2023

Feb 15, 2024

BUY
$5.09 - $10.79 $114,005 - $241,674
22,398 New
22,398 $221,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.31B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.